The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Fused Tetrahydroquinolines Are Interfering with Your Assay.EBI
University of North Carolina At Chapel Hill
Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic Optimization.EBI
Bristol Myers Squibb Research and Early Development
Cancer Immunotherapy through the Inhibition of Diacylglycerol Kinases Alpha and Zeta.EBI
Therachem Research Medilab
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.EBI
University of Piemonte Orientale
PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORSBDB
Actelion Pharmaceuticals
Indazole compound or salt thereofBDB
Taiho Pharmaceutical Co.
Compounds and probes for imaging huntingtin proteinBDB
CHDI Foundation, Inc.
Inhibitors of bacterial glutaminyl cyclases for use in the treatment of periodontal and related diseasesBDB
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung
BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOFBDB
Beigene Switzerland
MODIFIED PROTEINS AND PROTEIN DEGRADERSBDB
Cullgen (Shanghai)
Cereblon Ligands and Uses ThereofBDB
Regents Of The University Of Michigan
HETEROARYL CARBOXAMIDE COMPOUNDBDB
Astellas Pharma
COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERSBDB
Kineta
Alkyne-containing antiviral agentsBDB
Enanta Pharmaceuticals
SUBSTITUTED DIARYLAMINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOFBDB
Suzhou Yabao Pharmaceutical R&D Co.
SUBSTITUTED S-ALANINATE DERIVATIVESBDB
Bayer Aktiengesellschaft
Inhibiting mutant IDH-1BDB
Forma Therapeutics
Ethynyl derivativesBDB
Hoffmann-La Roche